Travere Therapeutics Inc (NASDAQ:TVTX) shares, rose in value on Thursday, March 27, with the stock price down by -2.02% to the previous day’s close as strong demand from buyers drove the stock to $20.37.
Actively observing the price movement in the last trading, the stock closed the session at $20.79, falling within a range of $20.34 and $21.18. The value of beta (5-year monthly) was 0.751. Referring to stock’s 52-week performance, its high was $25.29, and the low was $5.12. On the whole, TVTX has fluctuated by -3.14% over the past month.
With the market capitalization of Travere Therapeutics Inc currently standing at about $1.81 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-19.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 391.74M, with a low estimate of 72.1M and a high estimate of 94.5M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 77.53M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TVTX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of TVTX currently trading nearly 2.44% and -1.28% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.95, while the 7-day volatility ratio is showing 4.01% which for the 30-day chart, stands at 5.05%. Furthermore, Travere Therapeutics Inc (TVTX)’s beta value is 0.78, and its average true range (ATR) is 1.04.
A comparison of Travere Therapeutics Inc (TVTX) with its peers suggests the former has fared considerably weaker in the market. TVTX showed an intraday change of -2.02% in last session, and over the past year, it grew by 164.89%%.
Data on historical trading for Travere Therapeutics Inc (NASDAQ:TVTX) indicates that the trading volumes over the past 10 days have averaged 1.56 and over the past 3 months, they’ve averaged 1.60 million. According to company’s latest data on outstanding shares, there are 87.45 million shares outstanding.
Nearly 1.50% of Travere Therapeutics Inc’s shares belong to company insiders and institutional investors own 109.22% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.19 million shares as on 2025-03-14, resulting in a short ratio of 6.65. According to the data, the short interest in Travere Therapeutics Inc (TVTX) stood at 1395.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 11.3 million. The stock has risen by 16.93% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TVTX stock heading into the next quarter.
